Efficacy of Ultrasound-Guided C2 Nerve Root Pulsed Radiofrequency Combined with Extracorporeal Shock-Wave Therapy for Cervicogenic Headache: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500114770

Enrollment

Unknown

Registered

2025-12-17

Start date

2026-01-01

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervicogenic headache

Interventions

control group:none

ESWT group:Extracorporeal shock wave therapy

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Gender: male or female; 2.Age: 18–65 years; 3.Diagnosed with cervicogenic headache; 4.High level of cooperation, able to complete all required assessments; 5.Informed consent signed by the patient and family members; 6.Not participating in any other clinical trial.

Exclusion criteria

Exclusion criteria: 1.Severe cardiovascular, hepatic, or renal dysfunction; 2.History of serious drug allergy; 3.Psychiatric illness or cognitive impairment; 4.Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Headache frequency;Headache intensity score;Headache duration;Cervical spine functional status;Cervical hemodynamic parameters;	—

Secondary

Measure	Time frame
Post-treatment analgesic use;Adverse reaction incidence;	—

Countries

China

Contacts

Public ContactZhang Jialei

Changzhi People's Hospital Affiliated to Changzhi Medical College

zjlbigeye@163.com+86 159 3436 6259

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026